UNIGE’s synthetic anticoagulant provides reliable alternative to heparin

FHS
April 30, 2024
12:07 pm

Anticoagulant treatments are crucial for managing many conditions, such as heart disease, stroke and venous thrombosis.

Synexa Life Sciences enrols in My Green Lab certification program

Synexa Life Sciences, a global provider of biomarker and bioanalytical solutions to the pharmaceutical, biotech, and CRO industries, proudly announces its enrolment in the My Green

August 28, 2024

CDC Advisors Support Updated COVID Shots for All

The CDC’s Advisory Committee on Immunization Practices (ACIP) voted 13 to 1 in favor of recommending updated, monovalent, XBB-targeting COVID-19 shots for everyone age 6

September 13, 2023

Transcend Therapeutics and Yale awarded U.S. Department of Defense grant to study methylone for PTSD – Psychedelic Alpha

Company also announces that the IMPACT-1 clinical trial is underway with open-label results expected in the coming months NEW YORK, Sept. 21, 2023 /PRNewswire/ — Transcend

September 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.